For over a decade, facilitating Research Use Only (RUO) CRISPR studies has resulted in an increasing number of CRISPR-based cell and gene therapies used to treat patients with debilitating diseases. In this webinar, learn more about the requirements for the development of CRISPR-based therapeutics and navigating the regulatory landscape.

In this webinar, you will learn:

  • How to choose the optimal sgRNA quality at each stage of your research
  • Emerging trends and best practices for advancing toward clinical development
  • Navigating regulatory guidelines and avoiding potential obstacles